Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Epilepsy × Sirolimus × Clear all

Phase

Status

Recruiting 3 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Leukemia, Myeloid, Acute 19 Lymphoma, Non-Hodgkin 16 Hodgkin Disease 16 Myelodysplastic Syndromes 15 Multiple Myeloma 15 Lymphoma 15 Lymphoma, Mantle-Cell 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Leukemia 13 Graft vs Host Disease 12 Sarcoma 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 9 Tuberous Sclerosis 8 Neoplasms 8 Myeloproliferative Disorders 8 Lymphoma, B-Cell, Marginal Zone 8 Hematologic Neoplasms 8 Carcinoma, Hepatocellular 8 Burkitt Lymphoma 8 Recurrence 7 Neoplasm Metastasis 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Congenital Abnormalities 7 Carcinoma, Renal Cell 7 Breast Neoplasms 7 Waldenstrom Macroglobulinemia 6 Osteosarcoma 6 Neoplasms, Plasma Cell 6

Interventions

LY3295668 erbumine 2 Everolimus 2 ziprasidone 1 enzalutamide 1 clevidipine 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sirolimus 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nitrous Oxide 1 Nifedipine 1 Nafcillin 1 Molindone 1 Midazolam 1 Methylprednisolone 1 Mass Screening 1 Lurasidone Hydrochloride 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04595513 2024-05-16

STOP2

Children's Hospital Medical Center, Cincinnati

Phase 1/2 Completed

5 enrolled 15 charts

Epilepsy, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡